iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval. Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level, and approximately 40% faster processing on the new […]
iCad Inc.
iCad raises $12.5m
iCad (NSDQ:ICAD) announced that it entered into agreements for the purchase and sale of its common stock for gross proceeds of approximately $12.5 million. The agreements included the sale of more than 1.5 million shares of Nashua, N.H.-based iCad’s common stock at $8 per share. Craig-Hallum Capital Group is acting as financial advisor in connection with […]
iCad’s AI-assisted mammography tech wins CE Mark
iCad (NSDQ:ICAD) has won the CE Mark for its advanced artificial intelligence technology and workflow solution, ProFound AI for 2D mammography. The Nashua, N.H.-based cancer detection and radiation therapy devices maker developed the technology to boost breast cancer detection by identifying soft-tissue densities and calcifications. ProFound AI for 2D mammography is the latest addition to […]
iCad closes $10m offering
iCad (NSDQ:ICAD) yesterday closed a stock offering, including an underwriters option, that grossed more than $10 million. The Nashua, N.H.-based cancer detection and radiation therapy devices maker floated nearly 1.9 million shares at $5.50 apiece, including the 245,500-share over-allotment, for gross proceeds of roughly $10.3 million. The net proceeds of $9.5 million are earmarked for working […]
iCad prices $9m offering
iCad (NSDQ:ICAD) today priced a stock offering that’s slated to gross just more than $9.0 million. The Nashua, N.H.-based cancer detection and radiation therapy devices maker said it plans to float more than 1.6 million shares at $5.50 apiece, for expected net proceeds of about $8.3 million. The offering includes a 30-day underwriters option on […]
Wright Medical creates digital arm, promotes Asper to chief digital officer | Personnel Moves – May 7, 2019
Wright Medical (NSDQ:WMGI) said today that it is creating a new digital division and that it is promoting strategy, tech & corporate dev senior VP Jason Asper to chief digital officer. The new CDO title comes alongside Asper’s existing responsibilities, Amsterdam-based Wright Medical said. The new digital division will focus on the company’s digital surgery strategy […]
ReShape taps Allergan vet Bandy for CEO | Personnel Moves, April 3 2019
ReShape Lifesciences (NSDQ:RSLS) said last week that it named Allergan (NYSE: AGN) veteran Barton Bandy to replace Dan Gladney in the corner office, effective April 1. Gladney, who announced his retirement in January, is staying on as chairman. Bandy spent a decade at Inamed until its $3.2 billion purchase by Allergan in 2005. “I am […]
ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019
ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31. Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said. The company’s board of directors said they will immediately begin to look for a replacement, according to an […]
Former Rotation Medical CEO Shadan joins Miach Ortho | Personnel Moves – January 3, 2019
Early stage medtech firm Miach Orthopaedics said today that it named former Rotation Medical CEO and medtech vet Martha Shadan as its new prez and chief executive officer. Shadan has held numerous leadership positions at medtech firms, including Zimmer Biomet (NYSE:ZBH), Covidien, Bristol Myers Squibb and Merck, Westborough, Mass.-based Miach said. Prior to joining Miach, Shadan […]
iCad inks $7m private placement deal
iCad (NSDQ:ICAD) said this week that it landed a $7 million private placement deal with institutional investors. The company will pay interest to the investors on the outstanding principal amount at an annual rate of 5%, according to a report filed with the SEC. The convertible debentures mature on Dec. 21, 2021. Prior to the maturity […]
FDA names Flatiron Health’s Abernethy as deputy commish | Personnel Moves, December 19, 2018
The FDA this week named Amy Abernethy, the chief medical officer for Roche subsidiary Flatiron Health, as principal deputy commissioner to replace Rachel Sherman, who is retiring in January. “She’s a highly regarded thought leader who has held numerous positions of leadership in her fields of interest and distinguished herself for her intellect, her passion […]
